Related references
Note: Only part of the references are listed.Macrophage Phenotype and Function in Different Stages of Atherosclerosis
Ira Tabas et al.
CIRCULATION RESEARCH (2016)
Interleukin-4 regulates macrophage polarization via the MAPK signaling pathway to protect against atherosclerosis
X. N. Zhao et al.
GENETICS AND MOLECULAR RESEARCH (2016)
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis
Aldo Bonaventura et al.
MEDIATORS OF INFLAMMATION (2016)
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Jia Xue et al.
IMMUNITY (2014)
A significant correlation between C - reactive protein levels in blood monocytes derived macrophages versus content in carotid atherosclerotic lesions
Marielle Kaplan et al.
JOURNAL OF INFLAMMATION-LONDON (2014)
An optimized Protocol for Human M2 Macrophages using M-CSF and IL-4/IL-10/TGF-β Yields a Dominant Immunosuppressive Phenotype
S. Mia et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2014)
Vasoprotective effect of vitamin E: Rescue of ethanol-induced atherosclerosis and inflammatory stress in rat vascular wall
Alireza Shirpoor et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Macrophage M1/M2 Polarization Dynamically Adapts to Changes in Cytokine Microenvironments in Cryptococcus neoformans Infection
Michael J. Davis et al.
MBIO (2013)
In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation?
Jonathan D. Moore
NATURE REVIEWS CANCER (2013)
Inflammation in Atherosclerosis
Peter Libby
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Actions of antioxidants in the protection against atherosclerosis
Maria E. Loenn et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: A crucial role for Kruppel-like factor 2
L. J. H. van Tits et al.
ATHEROSCLEROSIS (2011)
No Reduction of Atherosclerosis in C-reactive Protein (CRP)-deficient Mice
Daniel Teupser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Crosstalk in NF-κB signaling pathways
Andrea Oeckinghaus et al.
NATURE IMMUNOLOGY (2011)
Puerarin Inhibits C-Reactive Protein Expression via Suppression of Nuclear Factor κB Activation in Lipopolysaccharide-Induced Peripheral Blood Mononuclear Cells of Patients with Stable Angina Pectoris
Xiangjun Yang et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
C-reactive protein is a mediator of cardiovascular disease
Radjesh J. Bisoendial et al.
EUROPEAN HEART JOURNAL (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
Macrophage Diversity and Polarization in Atherosclerosis A Question of Balance
Alberto Mantovani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
C-Reactive Protein and Coronary Disease Is There a Causal Link?
John Danesh et al.
CIRCULATION (2009)
Macrophage heterogeneity in atherosclerotic plaques
Jason L. Johnson et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
Cardiovascular Biology of Interleukin-6
Mahinda Y. Abeywardena et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Arginase I induction by modified lipoproteins in macrophages:: A peroxisome proliferator-activated receptor-γ/δ-mediated effect that links lipid metabolism and immunity
Alejandro Gallardo-Soler et al.
MOLECULAR ENDOCRINOLOGY (2008)
Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia
Alexander Kovacs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
PPARγ activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties
M. Amine Bouhlel et al.
CELL METABOLISM (2007)
Parthenolide modulates the NF-κB-mediated inflammatory responses in experimental atherosclerosis
Oscar Lopez-Franco et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Monocyte and macrophage heterogeneity
S Gordon et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Production of modified C-reactive protein in U937-derived macrophages
I Ciubotaru et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2005)
A proatherogenic role for C-reactive protein in vivo
A Paul et al.
CURRENT OPINION IN LIPIDOLOGY (2005)
Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages
B Fuhrman et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2005)
Concurrent treatment with renin-angiotensin system blockers and acetylsalicylic acid reduces nuclear factor kappa B activation and C-reactive protein expression in human carotid artery plaques
KJE Sattler et al.
STROKE (2005)
Regulation of basal and induced expression of C-reactive protein through an overlapping element for OCT-1 and NF-kappa B on the proximal promoter
B Voleti et al.
JOURNAL OF IMMUNOLOGY (2005)
Possible contribution of C-reactive protein within coronary plaque to increasing its own plasma levels across coronary circulation
T Ishikawa et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue
WJ Jabs et al.
CIRCULATION (2003)
Overexpressed nuclear factor-κB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPβ and signal transducer and activator of transcription-3
A Agrawal et al.
IMMUNOLOGY (2003)
Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris
T Ishikawa et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
High-sensitivity C-reactive protein in high-grade carotid stenosis: Risk marker for unstable carotid plaque
BA Garcia et al.
JOURNAL OF VASCULAR SURGERY (2003)
Share Paper
